Before creating a medicine, it is necessary to analyse its stability, interactions with the body, shelf life, and delivery method. The pharmaceutical business has evolved to apply genetic engineering to create 3rd generation pharmaceuticals, such as long lasting and quick acting insulin, erythropoietin, and the GM microorganism were used to improve the bio product of specific interest. a need for improving novel medicinal products for emerging disorders.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
